Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Advances in Desmuramyl Peptide Research (CROSBI ID 274440)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Ribić, Rosana ; Paurević, Marija ; Tomić, Srđanka Advances in Desmuramyl Peptide Research // Croatica chemica acta, 92 (2019), 2; 153-161. doi: 10.5562/cca3556

Podaci o odgovornosti

Ribić, Rosana ; Paurević, Marija ; Tomić, Srđanka

engleski

Advances in Desmuramyl Peptide Research

Immune adjuvants are added to vaccines in order to enhance the immune response to an antigen. Muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine, is the smallest structural unit of peptidoglycans showing the immunostimulating activity. Muramyl dipeptide analogues without the hydrophilic N- acetylmuramyl moiety are called desmuramyl peptides. Here, we provide review of desmuramyl peptides which were synthesized in order to improve the pharmacological properties of parent muramyl dipeptide, including our results regarding adamantane containing derivatives. Approach for future design of novel immunostimulators based on multiple pathogen recognition receptor activation was also considered.

adjuvant ; desmuramyl peptides ; immunostimulation ; pathogen recognition receptors

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

92 (2)

2019.

153-161

objavljeno

0011-1643

1334-417X

10.5562/cca3556

Povezanost rada

Kemija, Temeljne medicinske znanosti

Poveznice
Indeksiranost